Nemocnica S Poliklinikou Trebisov a.s.
- Address
- Slov. Nar. Povstania 76, 075 01 Trebišov, Slovakia
Nemocnica S Poliklinikou Trebisov a.s. - Ophthalmology Research Center
Nemocnica S Poliklinikou Trebisov a.s. is a specialized medical research facility with a strong focus on ophthalmology and retinal diseases. The center demonstrates particular expertise in conducting advanced clinical trials for vision-threatening conditions, utilizing cutting-edge intravitreal therapies and novel pharmaceutical interventions to preserve and restore visual function.
- Diabetic Macular Edema treatment studies comparing novel anti-VEGF agents
- Neovascular Age-related Macular Degeneration (wet AMD) combination therapy research
- Pediatric myopia progression prevention trials
The research center has established itself as a key site for evaluating innovative intravitreal treatments and next-generation therapeutic approaches in retinal disease management. Their portfolio includes comparative effectiveness studies of anti-VEGF therapies and novel ophthalmic solutions, with particular emphasis on measuring best-corrected visual acuity outcomes using standardized ETDRS methodology. The facility's diverse research scope extends from age-related retinal conditions to pediatric ophthalmology, positioning it as a comprehensive research center capable of addressing vision care needs across all age groups.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Eyebiotech Limited1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Eyebiotech Limited3trials
lock +1 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 353 other sites in Slovakia
Therapeutic Area Benchmark — Slovakia
Select a therapeutic area to compare against other sites in Slovakia.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Slovakia
Market Share
Country: Slovakia
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Nemocnica S Poliklinikou Trebisov a.s.
lock Showing 1 of 9 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 to Aflibercept in Participants with Diabetic Macular Edema | Eyepoint Inc. | Phase III | Recruiting | May 2026 | — |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aflibercept | 5 | Unknown | 2021-08-27 | 2026-06-22 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.